RO-28-1675 is a potent allosteric activator of glucokinase (EC50 = 54 nM) and is used in the research of type 2 diabetes; it can reverse the inhibitory effect of human glucokinase regulatory protein (GKRP); it reduces blood glucose levels in wild-type C57BL/6J mice following oral administration.